MENA Pharmaceutical Market Surpasses Brazil, China

Latest technologies and developments in pharmaceutical manufacturing will be on display, as the leading technology providers meet at the 5th MENA Pharmaceutical Manufacturing Congress and Exhibition on December 3, 2019.

The three-day event will also set the stage for the meeting of pioneers from the local and international pharmaceutical companies, CEOs, plant managers, production managers, supply chain managers, quality assurance managers, regulatory affairs managers, and engineers.

The MENA pharmaceutical market, which covers approximately 22 countries and represented 2% of the global market in 2016, now appears to be making a big leap showing a 10% projected growth, significantly outstripping the current global growth rate 4-6% and surpassing traditional ‘pharma-emerging’ economies such as Brazil and China. 

The figures provide a good prospect for international firms – both generic, and innovator focused – looking to enter a new market and expand their global footprint.

Driving the pharma market in the region, among others, are the rapidly changing population dynamics, where populations though ageing, is expanding. Apart from this, the life expectancy of average MENA inhabitant has gone up to 73 years, which is close to that of many developed nations.

As the lifestyle of MENA inhabitants changed, an increase in lifestyle-related and chronic diseases was seen - notably cardiovascular disease, obesity and type-2 diabetes. For the pharmaceutical industry, the diverse economic, cultural, and public health profiles in MENA are mirrored by a highly varied market environment.  Prospects are suitable for both foreign and domestic firms, with expanding populations and longer life expectancies creating a much higher demand for pharmaceuticals in the Middle East.

“Emerson is the leading automation partner of pharmaceutical manufacturers globally supporting their facilities to achieve top quartile performance, underpinned by our world-class technology solutions specifically designed for the regulated environment. To support the objectives of Saudi Vision 2030, Emerson has been investing in building local manufacturing, engineering, service, and R&D capabilities. With unrivalled experience in engineering solutions for the pharmaceutical manufacturing environment, we have been actively transferring this knowledge to build the capability in the Kingdom to support new and existing investors in the sector,” says Liam Hurley, Vice President & General Manager Saudi Arabia & Bahrain, Emerson Automation Solutions.

“The Middle East and North Africa region is one of the fastest growing economies in the world, with a population of over 380 million people and a growing economy.

Local governments have been more focus on the quality of healthcare, Medicine security and affordable medication. This has led to a large number of new international and local manufacturing facilities due to open across the Kingdom and the region, there is a great opportunity for pharmaceutical industry to farther establish them self and build new partnerships in the region,” says Waleed Rafaay, COO of Maarefah Management, the organizers of the show.

Experts predict further growth for the market in the region, which is likely to see individuals getting private health insurance, development of medical tourism, increases in domestic manufacturing, and better access to innovative drugs.

The MENA Pharmaceutical Manufacturing Congress, which will be held in light of this, will have a large exhibition area showcasing the latest machines and technologies used during the different pharmaceutical manufacturing stages, raw materials suppliers, regional manufacturers, contract manufacturers and more.